Evidence map›Paper›PMID 40991073›Full record

ArticleJournal of neurology2025

[

Yoshihiko Horimoto, Emi Hayashi, Yoshihiro Ito, Nobuyuki Okamura, Noriyuki Matsukawa

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yoshihiko HorimotoDepartment of Neurology, Nagoya City Rehabilitation Center, Nagoya, Japan. holly@chojuken.net.ORCID http://orcid.org/0000-0002-5133-281X
Emi HayashiDepartment of Radiology, Nagoya City Rehabilitation Center, Nagoya, Japan.
Yoshihiro ItoDepartment of Radiology, Nagoya City Rehabilitation Center, Nagoya, Japan.
Nobuyuki OkamuraDepartment of Pharmacology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Noriyuki MatsukawaDepartment of Neurology, Nagoya City University, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pathological processes in the early stages of multiple system atrophy (MSA) are still incompletely understood. Moreover, early-stage MSA is difficult to diagnose.

objectivesWe investigated the monoamine oxidase-B positron emission tomography findings with an aim to characterize degeneration in the early stages of MSA.

methodsPositron emission tomography using [

resultsUptake of [

conclusionsThe results of the presented patients suggest the potential diagnostic utility of [

Indexed as

Multiple System AtrophyParkinsonian DisordersTropanesAgedAminopyridinesFemaleFluorine RadioisotopesHumansMaleMiddle AgedPositron-Emission TomographyQuinolinesRadiopharmaceuticalsAminopyridinesFluorine RadioisotopesQuinolinesRadiopharmaceuticalsTHK5351Tropanes[18F]THK5351 positron emission tomography ([18F]THK5351 PET)Middle cerebellar peduncleMultiple system atrophy (MSA)Parkinson disease (PD)Progressive supranuclear palsy (PSP)

Identifiers

PMID40991073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.